Literature DB >> 4723271

Isotopic studies of the erythropoietic and hepatic components of congenital porphyria and 'erythropoietic' protoporphyria.

D C Nicholson, M L Cowger, J Kalivas, R P Thompson, C H Gray.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4723271     DOI： 10.1042/cs0440135

Source DB:  PubMed          Journal:  Clin Sci        ISSN： 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  7 in total

1.  Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces.

Authors:  G H Elder
Journal:  J Clin Pathol       Date:  1975-08       Impact factor: 3.411

2.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Congenital erythropoietic porphyria and congenital adrenal hyperplasia with evidence for hepatic delta-5 alpha-reductase deficiency.

Authors:  J A Miller; G M Levene
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

4.  'Erythropoietic' protoporphyria and cirrhosis in sisters.

Authors:  R P Thompson; E A Molland; D C Nicholson; C H Gray
Journal:  Gut       Date:  1973-12       Impact factor: 23.059

5.  Increased protoporphyrin in erythrocytes in a child with acute intermittent porphyria.

Authors:  A Gregor; E Kostrzewska; H Prokurat; Z Pucek; E Torbicka
Journal:  Arch Dis Child       Date:  1977-12       Impact factor: 3.791

6.  Pathogenesis and therapy of liver disease in protoporphyria.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb

7.  Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.